biochemistry: search

Journal of Plant Biology

biotechnology, biochemistry and macromolecular structure, cellular and developmental biology, ecology, genetics and genomics, molecular biology, morphology, physiology and taxonomy of plants.

Just a little squeeze lets proteins assess DNA

Nancy Horton, associate professor of biochemistry and molecular biophysics at the University of Arizona in Tucson.

Genetic Diseases More Complicated: Mechanism Underlying Alternative Splicing Of Premessenger RNA Into Messenger RNA Discovered

An international research team led by Tim Nilsen, Ph.D., a professor of medicine and biochemistry and the director of the School of Medicine's Center for RNA Molecular Biology, has discovered an unexpected mechanism governing alternative splicing, the process by which single genes produce different proteins in different situations. The new mechanism suggests that curing the more than half of genetic diseases that are caused by mutations in the genetic code that in turn create mistakes in alternative splicing may be considerably more complicated than biomedical researchers have previously assumed.

Chemistry professor 1 of only 3 at UH to achieve prestigious AAAS status

B. Montgomery Pettitt, the Hugh Roy and Lillie Cranz Cullen Professor of Chemistry and Professor of Physics, Computer Science, Biology and Biochemistry at the University of Houston, was awarded the...

How Genes And Proteins Interact To Build Life's Dynamic Architecture

While life on Earth didn't originate from a blueprint, Stephen Michnick is helping the scientific community uncover the basic architecture of living things. A Université de Montréal biochemistry professor and Canada Research Chair in Integrative Genomics, Dr. Michnick has developed novel technologies that have enabled him to examine how proteins interact within cells.

Time Magazine Top 10 Scientific Discoveries of 2008: Space and Physics Dominate

2008 has been an astounding year of scientific discovery. To celebrate this fact, Time Magazine has listed the "Top 10 Scientific Discoveries" where space exploration and physics dominate. Other disciplines are also listed; including zoology, microbiology, technology and biochemistry, but the number 1 slot goes to the most ambitious physics experiment of our time. Can you guess what it is? Also, of all our endeavours in space, can you pick out three that Time Magazine has singled out as being the most important?

Revolutionising diagnostics with some help from nature

Scientists from the EU-funded RECEPTRONICS project are turning to nature, and combining what they learn with the latest in nanotechnology, to find new ways of diagnosing cancer. The project, funded by the EU with EUR 1.99 million, brings together experts in the fields of biochemistry, bioengineering, nanotechnology and information technology.

Nanotechnology project RECEPTRONICS could lead to detecting diseases right at inception

(Nanowerk News) Scientists from the EU-funded RECEPTRONICS project are turning to nature, and combining what they learn with the latest in nanotechnology, to find new ways of diagnosing cancer. The project, funded by the EU with EUR 1.99 million, brings together experts in the fields of biochemistry, bioengineering, nanotechnology and information technology.

Revolutionising diagnostics with some help from nature

Scientists from the EU-funded RECEPTRONICS project are turning to nature, and combining what they learn with the latest in nanotechnology, to find new ways of diagnosing cancer. The project, funded by the EU with EUR 1.99 million under the Sixth Framework Programme (FP6), brings together experts from four European countries in the fields of biochemistry, bioengineering, nanotechnology and information technology.

Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics

PALO ALTO, Calif., Dec. 2 /PRNewswire/ -- Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced the issuance of United States patent 7,459,547, entitled "Methods and Compositions for Controlling Efficacy of RNA Silencing." The issued patent, which is based on the seminal research of Philip Zamore, Ph.D., the Gretchen Stone Cook Chair of Biomedical Sciences and Professor of Biochemistry & Molecular Pharmacology at

Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency...

Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics Zamore Patent Covers Methods for Enhancing RNAi Structural Features and Strengthens Intradigm's Competitive Position PALO ALTO, Calif., Dec. 2 /PRNewswire/ -- Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced the issuance of United States patent 7,459,547, entitled "Methods and Compositions for Controlling Efficacy of RNA Silencing." The issued patent, which is based on the seminal research of Philip Zamore, Ph.D., the Gretchen Stone Cook Chair of Biomedical Sciences and Professor of Biochemistry & Molecular Pharmacology at University of Massachusetts Medical School, generally claims methods of enhancing the RNA silencing activity of an RNAi agent through certain str

Search took 0.01 seconds.